Transformative Pharmaceutical Solutions (TPS) offers customized, technology-enabled solutions to Sponsor companies and Investigative Sites conducting clinical trials. By combining our state of the art technology with built-in workflow, redefined roles and processes, our solutions increase operational transparency, efficiencies, and quality while considerably decreasing cost.

May 1, 2017 - TPS announces the rollout of its new solution, Adaptive Site Management (ASM), with a patent pending Process and Technology. This solution uses a Site Standardization Platform (SSP) that allows transparency between site operations and Sponsor directives.

Process

Other processes leave you in the dark. Our processes are transparent.

Built-in comprehensive, documented, intuitive workflows enable functional groups to communicate, track and manage all actions within the clinical trial process. The transparency of our processes provides more than oversight. It gives the sponsor informed control, which delivers enhanced quality while driving a significant decrease in R&D cost.

Inspection & Regulation Ready

Enhanced Quality

Real-time Oversight

Technology

Other technologies identify your problems. Ours predicts them.

Our proprietary Risk Assessment Platform and Targeted Operational Response System (RAPTOR℠) comprises a suite of interoperable modules, inclusive of 80+ clinical and operational interactive data displays, and an advanced statistical and analytical engine. RAPTOR℠ predictive algorithms allow you to move from issue management (re-active) to complete control through risk management (pro-active).

Agnostic System Integration

Interactive Visualizations

Predictive Recommendations

People

Other providers leave you on your own. Our experts are with you every step of the way.

The TPS management team has extensive experience implementing the largest personnel solutions in the industry. This includes integrated/embedded programs, satellite operations, rescues and conversions. Through our internal niche recruitment engines, our teams are built based on custom Sponsor requirements, including therapeutic and operational expertise. Each TPS employee is hand-selected by the Sponsor and fully dedicated for the duration of the program.

Scalable & Flexible

Sponsor Branded

High Retention

What You Get

Sponsor Retains Strategic Control of Drug Development
Hand-Selected Project Teams
Operational Transparency
Niche Recruitment Engines
True Integrated RBM with Adaptive Monitoring Platform
Cost++ Pricing Methodology
Change Orders
TPS
Sponsor Retains Strategic Control of Drug Development
Hand-Selected Project Teams
Operational Transparency
Niche Recruitment Engines
True Integrated RBM with Adaptive Monitoring Platform
Cost++ Pricing Methodology
Change Orders
CRO
Sponsor Retains Strategic Control of Drug Development
True Integrated RBM with Adaptive Monitoring Platform
Change Orders
Technology Companies
Sponsor Retains Strategic Control of Drug Development
Hand-Selected Project Teams
Niche Recruitment Engines
True Integrated RBM with Adaptive Monitoring Platform
Cost++ Pricing Methodology
Change Orders

Our Solutions

TPS brings innovative, customized, technology-enabled solutions to market that serve as alternatives to traditional outsourcing.  In addition, TPS offers individual assignments, rescues, FSPs, and integrated programs.

Want to know more?

Use the form below to request a datasheet further outlining our solutions.

Customized Integrated Solutions

TPS offers customized sourcing models in which our teams, systems and processes are integrated within a Sponsor organization. This allows us to manage the ebb and flow of resourcing while providing the Sponsor the ability to maintain strategic control. Each integrated program is designed around the Sponsor's current structure and can extend from a single service to portfolio management across multiple functions.

  • Functional Service Provider
  • Vendor Oversight
  • Project Crisis Rescue
  • Resource Staffing
  • Conversion Option

iAM (Risk Based Monitoring)

Integrated Adaptive Monitoring (iAM) is the industry’s first and only truly complete RBM solution. iAM addresses all aspects of Quality Risk Management through the incorporation of people, process and technology thus yielding the greatest impact on quality, effectiveness and savings.

Site Standardization Platform (SSP)

This novel solution is for Sponsor companies only.  Please contact us to learn more.

Adaptive Site Management (ASM)

ASM combines our novel technology with our Site Standardization Platform (SSP) enabling transparency between site operations and Sponsor directives. This novel solution is for Sponsor companies only.  Please contact us to learn more.

Who We Are

Our Executive Team

Who We Are

Our Executive Team

Daniel M. Perlman
Chief Executive Officer

Daniel has over 20 years of experience as a leader in the Life Sciences industry, implementing significant disruptive programs that have revolutionized clinical trial conduct. Daniel’s solutions are based on the premise that Pharmaceutical and Biotechnology companies need to maintain core competencies in-house and outsource non-core competencies, and that the ideal operating scenario involved an integrated methodology (providing sponsors with transparency and allowing them to maintain strategic control).

Daniel brought the Functional Service Provider (FSP) model (1998) and Embedded Solutions model (2009) to the industry. For his work, Daniel was awarded the Industry Innovation Award in 2012.

Daniel founded ReSearch Pharmaceutical Services, Inc. (RPS) in 1998 and was its Chairman and Chief Executive Officer through 2013. Under Daniel’s leadership, RPS grew to approximately $500 million in annual revenue and 5,000 employees operating in over 70 countries by 2013. RPS established itself as a top tier global Contract Research Organization (CRO) with an annualized compounded growth rate of greater than 30%.

RPS went public on the London Alternative Investment Market in 2008, and was subsequently listed on NASDAQ. RPS was acquired by the private equity firm Warburg Pincus in 2011, and subsequently purchased by KKR in 2013 at which time the organization was merged with PRA.

Prior to starting RPS, Daniel served as Executive Vice President of Operating Specialties for Kforce, Inc. from 1993 to 1998. Daniel established and subsequently grew the Pharmaceutical Division, Healthcare Division, Engineering Division, Scientific Division, Legal Division, and Human Resources Division. Kforce’s revenue grew from approximately $50M in 1995 to approximately $1 billion in 1998.

Originally from the Philadelphia area, Daniel graduated from The Haverford School (1974) and from the University of Pennsylvania, Wharton School of Business (1979).

 

Michael F. Smith, Ph.D.
President

Michael has over twenty years’ experience in the Life Sciences industry. Prior to joining TPS, Michael was Vice President and Head of Global Clinical Operations at Novartis Pharmaceuticals where he had responsibility for all aspects of Clinical Trial Operational Management for a global organization spanning 50+ countries and 200+ clinical trials. He led multiple strategic initiatives and innovations directed at improving quality, compliance, efficiency and patient safety with a specific emphasis on analytics and technology-enabled risk-based monitoring paradigms.

Prior to joining Novartis, Michael was Vice President, Global Site Management at Wyeth Pharmaceuticals where he was an early leader in the development of flexible, integrated monitoring models. Previously, Michael held many additional senior positions in Clinical Research and Development at Pfizer and Parke-Davis and has participated on multiple industry advisory boards and networks. Michael holds a Ph.D. in Biophysics from the University of Michigan.

Stephen T. Burdumy
Executive Vice President and Chief Operating Officer

Prior to joining TPS, Stephen was a Partner in the Corporate and Securities Group of the national law firm of Drinker, Biddle & Reath, LLP, where, among other clients, he acted as outside general counsel to RPS. While at Drinker Biddle, Stephen served three terms as a Managing Partner. Stephen has over nineteen years’ experience with companies in the Life Sciences, Medical Device and CRO industries, with a focus on capital markets, mergers and acquisitions, and general corporate matters. Stephen holds a Juris Doctor Degree from the University of San Francisco, and a B.S.F.S. in International Economics (with a concentration in International Finance and Commerce) from the Georgetown University School of Foreign Service.

Syed Shah
Executive Vice President, Clinical and Global Operations

Dr. Shah has nineteen years’ experience in the Life Sciences industry. Prior to joining TPS, Dr. Shah was Global Head of Strategic Planning & Operations, Global Clinical Operations at Novartis AG. Throughout his career in Research & Development, his ability to analyze needs and work across a variety of geographies to create unique solutions designed to yield optimal outcomes, has proven to be invaluable for the multi-national Pharmaceutical companies. Dr. Shah has previously worked for GSK and GE Healthcare. Dr. Shah holds a B.Sc. and Ph.D. in Chemistry from the University of London.

Aly Heffelfinger
Executive Vice President, Global Human Resources

Ms. Heffelfinger has twenty years' experience in the Life Sciences industry. Prior to joining TPS, Ms. Heffelfinger was the Executive Vice President, Global Human Resources at RPS and was responsible for the development and management of the Global HR function. Ms. Heffelfinger served as a member of the Executive Leadership team at RPS. Prior to joining RPS, she was employed by biotechnology company in New York. She holds a Bachelor’s Degree in Marketing and Corporate Law from Temple University’s School of Business.

Gina Willson
Executive Vice President Business Operations

Gina has over twenty years’ experience in the Life Sciences industry.  Prior to joining TPS, Gina was Vice President, Global Strategic Operations for RPS, and was responsible for establishing and managing the Global Proposal, Feasibility, Investigator Recruitment and Clinical Vendor Strategy Departments.  She served as a member of the Executive Leadership Team and a member of the Clinical Innovations Team with a focus on applying novel solutions to clinical operations.  Prior to joining RPS, Gina was the Director, Clinical Operations at Acurian.  Gina holds a Bachelor’s Degree in Biology from Rosemont College.

Joshua Perlman
Executive Vice President, Strategic Development

Joshua has ten years’ experience in the Life Sciences industry. Prior to joining Transformative Pharmaceutical Solutions, Joshua served as Regional Director of Asia-Pacific Resourcing at RPS, and was based in the Beijing, China regional headquarters. He was responsible for the establishment of Asia-Pacific Operations and the Regional Recruitment divisions. During his tenure in Beijing, Joshua and his teams were successful in expanding the RPS regional operations and support teams, and under his guidance, RPS became the fastest growing CRO in Asia-Pacific region. Joshua served as a board member for the RPS-Asklep joint venture in Japan. Prior to this role, Joshua spent four years in the US headquarters in various roles within recruitment with a specific focus on expanding business lines.

Dana Durkan
Executive Vice President, Global Recruitment

Ms. Durkan has fifteen years’ experience in the Life Sciences industry. Prior to joining TPS, Ms. Durkan served as Director of Talent Acquisition for the North American and Latin American regions of PRA Health Sciences, and its predecessor, RPS. While at the combined organizations, she was instrumental in building the industry’s first global recruitment engines to deliver Sponsor project teams for Embedded Programs. Prior to RPS, Ms. Durkan worked in the competitive intelligence field for two years. Ms. Durkan holds a Bachelor’s Degree in Biology from Bloomsburg University.

David Willson
Executive Vice President, Innovative Site Solutions

David has sixteen years’ experience in the Life Sciences industry. David is Executive Vice President, supporting innovative site solutions and recruitment. Prior to joining TPS, he served as the North America Manager of Talent Acquisition for PRA Health Sciences, and its predecessor, RPS. He was responsible for the oversight of recruitment teams as well as acting as a strategic client interface. Before assuming a management role, he was a Global Recruitment Lead across all functions within clinical drug development. He received his Bachelor’s Degree in Marketing and Management from Kutztown University.

Sean P. Quinn
Executive Vice President, Global Marketing

Mr. Quinn has twenty-eight years’ experience in the Life Sciences industry. Prior to joining TPS, Mr. Quinn was Executive Director of Global Marketing for 12 years at ReSearch Pharmaceutical Services (RPS). Prior to joining RPS, Mr. Quinn held multiple positions at IBAH/Omnicare Clinical Research in Information Technology, Global Proposals and Corporate Marketing. Mr. Quinn has also held positions with Acurian, The Inseption Group, Ancillare and the Philadelphia Phillies. Mr. Quinn holds and Bachelor’s Degree in Organizational Management from Eastern University.

Why work for a CRO or staffing company when TPS offers career opportunities that truly maximize your potential?

Not only do our Clients benefit from our solutions, but our employees do as well. By working directly for TPS, our employees enjoy fully-dedicated assignments with the security and benefits of a permanent position.  Our consultative approach throughout the recruitment process provides the opportunity to work in an area of interest and expertise.

Ready for Solutions? Let’s Talk.

Files must be less than 2 MB.
Allowed file types: txt rtf pdf doc docx odt.
Business Development
Marketing & Media